Journal of the Chinese Medical Association
Volume 73, Issue 2 , Pages 88-92 , February 2010

The Unusual Presentation of Gastric Adenocarcinoma as a Testicular Mass: A Favorable Response to Docetaxel and Cisplatin Plus Oral Tegafur/Uracil and Leucovorin

  • Kai-Chung Yang

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • ,
  • Yee Chao

      Affiliations

    • Cancer Center, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • Central Clinic Hospital, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • ,
  • Jiing-Chyuan Luo

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • ,
  • Junne-Yih Kuo

      Affiliations

    • Division of Genitourology, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • ,
  • Rheun-Chuan Lee

      Affiliations

    • Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • ,
  • Anna Fen-Yau Li

      Affiliations

    • Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • ,
  • Chung-Pin Li

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • Corresponding Author InformationCorrespondence to: Dr Chung-Pin Li, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C.

Received 8 June 2009 ,Accepted 25 November 2009.

References 

  1. Ferlay J , Bray F , Parkin DM , Pisani P . Globocan 2000: Cancer Incidence and Mortality Worldwide. IARC Cancer Bases No. 5 . Lyon: IARC Press; 2001;
  2. Lau M , Le A , El-Serag HB . Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival . Am J Gastroenterol . 2006;101:2485–2492
  3. Turan T, Aykan B, Koc S, Boran N, Tulunay G, Karacay O, et al  Analysis of metastatic ovarian tumors from extragenital primary sites . Tumori . 2006;92:491–495
  4. Kakushima N, Kamoshida T, Hirai S, Hotta S, Hirayama T, Yamada J, et al  Early gastric cancer with Krukenberg tumor and review of cases of intramucosal gastric cancers with Krukenberg tumor . J Gastroenterol . 2003;38:1176–1180
  5. Grignon DJ , Shum DT , Hayman WP . Metastatic tumours of the testes . Can J Surg . 1986;29:359–361
  6. Kaufman DS , Saksena MA , Young RH , Tabatabaei S . Case records of the Massachusetts General Hospital. Case 6-2007. A 28-year-old man with a mass in the testis . N Engl J Med . 2007;356:842–849
  7. Dutt N , Bates AW , Baithun SI . Secondary neoplasms of the male genital tract with different patterns of involvement in adults and children . Histopathology . 2000;37:323–331
  8. Haupt HM , Mann RB , Trump DL , Abeloff MD . Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms . Cancer . 1984;54:709–714
  9. Qazi HA , Manikandan R , Foster CS , Fordham MV . Testicular metastasis from gastric carcinoma . Urology . 2006;68:890; e7–8.
  10. Niehans GA , Manivel JC , Copland GT , Scheithauer BW , Wick MR . Immunohistochemistry of germ cell and trophoblastic neoplasms . Cancer . 1988;62:1113–1123
  11. Iczkowski KA , Butler SL . New immunohistochemical markers in testicular tumors . Anal Quant Cytol Histol . 2006;28:181–187
  12. Shah MA , Schwartz GK . Treatment of metastatic esophagus and gastric cancer . Semin Oncol . 2004;31:574–587
  13. Ajani JA . Evolving chemotherapy for advanced gastric cancer . Oncologist . 2005;10:49–58
  14. Sulkes A, Smyth J, Sessa C, Dirix LY, Vermorken JB, Kaye S, et al  Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group . Br J Cancer . 1994;70:380–383
  15. Roth AD, Maibach R, Martinelli G, Fazio N, Aapro MS, Pagani O, et al  Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO) . Ann Oncol . 2000;11:301–306
  16. Ohtsu A, Boku N, Tamura F, Muro K, Shimada Y, Saigenji K, et al  An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer . Am J Clin Oncol . 1998;21:416–419
  17. Dank M, Zaluski J, Barone C, Valvere V, Yalcin S, Peschel C, et al  Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction . Ann Oncol . 2008;19:1450–1457
  18. Ajani AJ, Fodor MB, Tjulandin SA, Moiseyenko VM, Chao Y, Filho SC, et al  Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma . J Clin Oncol . 2005;23:5660–5667

PII: S1726-4901(10)70007-1

doi: 10.1016/S1726-4901(10)70007-1

Journal of the Chinese Medical Association
Volume 73, Issue 2 , Pages 88-92 , February 2010

Article Tools